4
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Patients' views on the least acceptable increase in survival with zidovudine treatment

Pages 509-510 | Published online: 08 Jul 2009

References

  • Armitage P, Berry G. Statistical methods in medical research. Blackwell, Oxford 1987
  • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406–412
  • Slevin M L, Stubbs L, Plant H J, Wilson P, Gregory W M, Armes P J, Downer S M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 1990; 300: 1458–1460
  • Nordic Medical Research Councils' HIV Therapy Study Group. Double‐blind dose‐response study of zidovudine in serious HIV infection and AIDS. Sixth Int Conference on AIDS, abstract S. B. 451, San Francisco, June, 20–241990
  • Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard P M, Perrone C, Salmon D, de Truchis P, Leport C, Bouvet E, Dazza M C, Levacher M, Regnier B. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS‐related complex. Lancet 1988; 2: 1297–1302
  • Andersen P K. Conditional power calculations as an aid in the decision whether to continue a clinical trial. Controlled Clin Trials 1987; 8: 67–74

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.